{4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis]
RxNorm concept 2680757, branded pack (bpck). Prescribable name: CYLTEZO Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count).
- RxCUI
- 2680757
- Term type
- Branded pack (BPCK)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2680757 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis/Uveitis (4 count)
Related concepts
- 0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo] (SBD, contains)
- Pack (DF, has dose form)
- {4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector) } Pack (GPCK, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2680757 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2680757 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2680757. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.